Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

164.92
+1.741.07%
Volume:1.19M
Turnover:196.27M
Market Cap:22.13B
PE:-47.07
High:167.90
Open:164.54
Low:161.22
Close:163.18
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.58
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-99.30
PE(LYR):-49.67

Loading ...

Goldman Sachs Sticks to Their Buy Rating for Guardant Health (GH)

TIPRANKS
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Annexon Biosciences (ANNX) and Guardant Health (GH)

TIPRANKS
·
Jul 15

Guardant Health is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Guardant Health price target raised to $205 from $135 at Canaccord

TIPRANKS
·
Jul 14

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

GlobeNewswire
·
Jul 13

S&P 500 Futures Flat in Premarket Trading; Circle Internet Group, Moog Lead

Dow Jones
·
Jul 10

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Dow Jones
·
Jul 10

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 10

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Movement Alert|Guardant Health Rises 5.21% in Regular Trading, BofA Raises Price Target to $190

Market Focus
·
Jul 09

Guardant Health price target raised to $175 from $130 at Morgan Stanley

TIPRANKS
·
Jul 09

Guardant Health is Maintained at Buy by Citigroup

Dow Jones
·
Jul 09

Guardant Health price target raised to $215 from $150 at Citi

TIPRANKS
·
Jul 08

BofA Securities Adjusts Price Target on Guardant Health to $190 From $135

MT Newswires Live
·
Jul 06

Guardant Health is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 06

Guardant Health price target raised to $190 from $135 at BofA

TIPRANKS
·
Jul 06

Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion

Simply Wall St.
·
Jul 05

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)

TIPRANKS
·
Jul 03

Zydus Lifesciences Signs Mou with Apollo Hospitals

Reuters
·
Jul 03

Guardant Health: Buy Rating Reaffirmed as UnitedHealth Coverage Expands Shield Access; 12-Month Price Target Maintained at $165

TIPRANKS
·
Jul 02